• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Vaccines

Pharma

JPM: GSK's Miels talks RSV and mRNA vaccines, oncology setbacks

In a wide-ranging convo with GSK's commercial chief, a Zejula combo trial with Jemperli has very low chance of success.
Angus Liu Jan 11, 2023 5:45pm
image-icon

2022 drug approvals: Biopharma delivered 37 new drugs

Jan 3, 2023 3:00am

Vaccine patch passes clinical test, supporting further trials

Dec 20, 2022 7:30am

Vaxxas raises $23M to fund needle-free COVID-19 vaccine trial

Dec 6, 2022 10:25am

LTS Lohmann leads investment in needle-free delivery specialist

Nov 29, 2022 10:53am

Moderna pads the case for its bivalent COVID-19 booster

Nov 14, 2022 12:13pm
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy